• 1510 Citations
  • 18 Scopus h-Index
19952018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Candido E Rivera is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 33 Similar Profiles
Primary Myelofibrosis Medicine & Life Sciences
Paroxysmal Hemoglobinuria Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Prednisone Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
von Willebrand Factor Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2018

  • 1510 Citations
  • 18 Scopus h-Index
  • 31 Article
  • 1 Letter
1 Citation (Scopus)

Diagnosis and Management of Genetic Iron Overload Disorders

Palmer, W. C., Vishnu, P., Sanchez, W., Aqel, B., Riegert-Johnson, D., Seaman, L. A. K., Bowman, A. W. & Rivera, C. E., Jan 1 2018, (Accepted/In press) In : Journal of General Internal Medicine.

Research output: Contribution to journalArticle

Iron Overload
Iron
Endocrine Glands
Mutation
Phlebotomy
5 Citations (Scopus)

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, G., Habermann, T. M. & 3 others, Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Nov 1 2018, In : Blood Cancer Journal. 8, 11, 108.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Survival
Neoplasms
Germinal Center

Pharmacokinetics-based clinical management of acquired von willebrand syndrome: A case report

Baldeo, C. M., Rivera, C. E., Tun, H. W. & Vishnu, P., Jan 19 2018, In : Journal of Blood Medicine. 9, p. 9-13 5 p.

Research output: Contribution to journalArticle

von Willebrand Factor
Pharmacokinetics
von Willebrand Diseases
Deamino Arginine Vasopressin
Type 1 von Willebrand Disease

Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers

Vishnu, P., Vanegas, Y. M., Wadei, H. M. & Rivera, C. E., Jan 1 2018, In : BMJ Case Reports. 2018, bcr-2018-224622.

Research output: Contribution to journalArticle

Polycythemia
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Transplants
Phlebotomy
29 Citations (Scopus)

A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis

Gupta, V., Mesa, R. A., Deininger, M. W. N., Rivera, C. E., Sirhan, S., Brachmann, C. B., Collins, H., Kawashima, J., Xin, Y. & Verstovsek, S., 2017, In : Haematologica. 102, 1, p. 94-102 9 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Janus Kinase 1
Spleen
Janus Kinase 2
Cytokines